3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
NCT00365950 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2400
Last updated 2006-08-18
Summary
To determine whether 3 months' anticoagulation is as good as or better than 6 months' for the treatment of DVT/PE
Conditions
- Deep Vein Thrombosis
- Pulmonary Embolism
- Deep Vein Thrombosis With Pulmonary Embolism
Interventions
- DRUG
-
Duration of anticoagulation
- DRUG
-
Warfarin duration
Sponsors & Collaborators
-
British Thoracic Society
lead OTHER
Principal Investigators
-
Aziz Sheikh, MD,FRCGP · Research Committee of the British Thoracic Society
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-09-30
- Completion
- 2003-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.
NCT01382550 ·Status: UNKNOWN
-
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
NCT00633893 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Duration of Anticoagulation in Deep Venous Thrombosis
NCT01285661 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation
NCT00621491 ·Status: COMPLETED ·Phase: NA
-
Secondary Prevention of Venous Thrombo Embolism (VTE).
NCT00329238 ·Status: COMPLETED ·Phase: PHASE3
-
Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.
NCT00740883 ·Status: COMPLETED ·Phase: PHASE3
-
Predictors of Anticoagulation Control on Warfarin Therapy
NCT00905177 ·Status: COMPLETED
-
Direct Oral Anticoagulants and Venous Thromboembolism
NCT02833987 ·Status: COMPLETED
-
Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy
NCT02979561 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants
NCT02161731 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
NCT00643201 ·Status: COMPLETED ·Phase: PHASE3
-
REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.
NCT03285438 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study
NCT03895502 ·Status: COMPLETED ·Phase: PHASE4
-
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
NCT00024297 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial
NCT01124058 ·Status: COMPLETED ·Phase: PHASE1
-
The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism
NCT03185845 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism
NCT00291330 ·Status: COMPLETED ·Phase: PHASE3
-
DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation
NCT00806624 ·Status: COMPLETED ·Phase: PHASE2
-
Does Anticoagulant Control Change Following Referral Back to the Primary Care Physician?
NCT00735189 ·Status: COMPLETED ·Phase: PHASE4
-
Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)
NCT00680186 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study
NCT00252005 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
NCT03147638 ·Status: UNKNOWN ·Phase: PHASE3
-
LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin
NCT00321009 ·Status: COMPLETED ·Phase: NA
-
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
NCT02744092 ·Status: COMPLETED ·Phase: NA
-
Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
NCT00448214 ·Status: COMPLETED ·Phase: PHASE2